Confidence in Compliance: Genotoxic Impurity Analysis
Detecting genotoxic or carcinogenic impurities in pharmaceutical products is essential to ensuring their safety and compliance. Failure to confirm that products are contaminant- and impurity-free may require companies to launch costly investigations, halt production, or face product recall.
Stringent safety requirements associated with the analyses of carcinogenic and mutagenic impurities can present significant challenges. Methods must achieve a high level of sensitivity and selectivity while maintaining sufficient sample throughput.
Discover a best-in-class solution for the confident analyses of genotoxic impurities.
Download this smart note to explore:
- LC-MS solutions that ensure excellent precision and sensitivity
- High-throughput workflows that offer speed and flexibility
- Columns, solvents and consumables for optimal analytical performance